altRx vs bmiMD: Pricing, access, and program differences
Quick verdict: In an altRx vs bmiMD comparison, altRx is the lower-cost, no-commitment option with a limited offer for compounded semaglutide from $89/mo and compounded tirzepatide from $149/mo, while bmiMD focuses on compounded tirzepatide with multi-month pricing that drops to $139/mo but requires longer prepaid commitments for the lowest rate.
How altRx vs bmiMD differ at a glance
The most important differences between altRx and bmiMD are pricing structure, medication focus, shipping and turnaround, commitment and billing options, and clinician access. These points drive which program fits a given patient.
1. Pricing and billing options
altRx advertises a limited offer: compounded semaglutide starting at $89/month and compounded tirzepatide starting at $149/month. altRx also lists multi-month discounts in its FAQ that drop semaglutide to $85/mo on 3 months and as low as $75/mo on 12 months, and similar multi-month reductions for tirzepatide. altRx emphasizes no membership, no hidden fees, and pay-later options with Affirm, Klarna, Afterpay.
bmiMD offers compounded tirzepatide with four billing options: $179 month-to-month, $159/mo on a 3-month plan, $149/mo on a 6-month plan, and $139/mo on a 12-month plan. bmiMD notes the lowest price requires a 12-month commitment and advises confirming the total prepaid charge.
2. Medication offerings and formulation
altRx markets both compounded semaglutide (GLP-1) and compounded tirzepatide (GLP-1/GIP) as part of its program. The site repeatedly notes these are compounded medications and includes the regulatory note that compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality.
bmiMD, as captured, emphasizes compounded tirzepatide (GLP-1/GIP) and also includes the regulatory note that compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality.
3. Shipping, turnaround and kit contents
altRx advertises free, discreet 2-day delivery and a complete treatment kit that includes vials, syringes, prep pads, and step-by-step guidance. Typical processing and delivery time is approximately 4–5 business days after prescription fulfillment.
bmiMD advertises free subscription shipping on every order and states prescriptions are prepared in a state-licensed pharmacy and delivered to your door; captured copy highlights reliable refills and timely arrival but does not specify a 2-day delivery promise.
See altRx delivery and kit details
4. Commitment, cancellations, and refunds
altRx promotes no commitment and cancel anytime membership terms and says there are no membership, insurance or hidden fees. altRx also highlights buy-now-pay-later options. bmiMD offers a 100% refund if a patient is not eligible for the program and notes the lowest monthly equivalent requires a longer prepay commitment; bmiMD advises confirming the total prepaid charge.
5. Clinician review and ongoing support
altRx states medical oversight is included in the monthly fee, with a licensed provider reviewing the health evaluation and conducting telehealth consultations, and a care team available throughout membership. bmiMD highlights 24/7 clinician access and online refills and delivery, with clinician confirmation of treatment appropriateness.
Comparison table: altRx vs bmiMD
| Criteria | altRx | bmiMD |
|---|---|---|
| Starting price | Semaglutide $89/mo; Tirzepatide $149/mo | Tirzepatide $179/mo month-to-month; $139/mo on 12-month plan |
| Medications offered | Compounded semaglutide and compounded tirzepatide | Compounded tirzepatide |
| Shipping | Free, discreet 2-day delivery; typical 4–5 business days | Free subscription shipping on every order |
| Commitment | No commitment; cancel anytime | Lowest price requires 12-month commitment; confirm total prepaid charge |
| Clinician access | Licensed provider review and ongoing care team support | 24/7 clinician access; online refills |
| Regulatory note | Compounded medications are not FDA-approved | Compounded medications are not FDA-approved |
Primary keyword: altRx vs bmiMD
Both providers operate on a direct-pay telehealth model for compounded GLP-1 or GLP-1/GIP products and include clinician review before treatment; the primary differences are price and commitment structure, medication selection, and delivery promises.
Short conclusion and recommendation
altRx offers the lowest advertised starting price and no-commitment enrollment, making it a clear choice for patients whose priority is the lowest monthly outlay and flexible cancellation. bmiMD is focused on tirzepatide with structured multi-month plans that lower the monthly equivalent to $139 only with a 12-month commitment and emphasizes 24/7 clinician access and free subscription shipping.
Choose altRx if…
- You want the lowest advertised starting price and no membership or long-term commitment; altRx advertises compounded semaglutide from $89/mo and tirzepatide from $149/mo and says you can cancel anytime.
Choose bmiMD if…
- You plan to commit to a longer prepaid plan for a lower long-term monthly equivalent and prefer a tirzepatide-focused program with free subscription shipping; bmiMD lists $139/mo on a 12-month plan and offers 24/7 clinician access.
Note: Both providers state their compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality. Treatment is available only when a licensed clinician determines it is medically appropriate.
Ready to Compare Telehealth Providers?
Explore leading providers — physician-supervised, all-inclusive pricing, and free home delivery.
Compare All Providers →